Table III.

Distribution of patients for each score of the Katagiri scoring system.

A, Proportion of patients
Prognostic factors	Kagoshima	Katagiri (2005)	P-value
Primary lesiona			0.65b
Rapid growth	52	132
Moderate growth	42	74
Slow growth	51	144
Visceral and cerebral metastasis			<0.01c
Yes	37	178
No	108	172
Performance status (ECOG)			<0.01c
3 or 4	61	219
1 or 2	84	131
Previous chemotherapy			0.47c
Yes	46	108
No	99	241
Skeletal metastases			<0.01c
Multiple	80	238
Single	65	112
B, Katagiri scoring
Scoring	All patients Kagoshima	All patients Katagiri (2005)	P-value
0–2	31	23	<0.01b
3–5	54	67
6–8	60	156
C, Katagiri scoring
Prognostic score	Months	Survival rate (%)	95% CI
0–2 points	3	78.0	0.66–0.90
	6	69.7	0.56–0.84
	12	66.5	0.52–0.81
	24	38.2	0.20–0.57
3–5 points	3	63.5	0.52–0.75
	6	52.0	0.40–0.64
	12	29.0	0.17–0.41
	24	21.8	0.11–0.33
6–8 points	3	64.5	0.45–0.84
	6	29.8	0.10–0.49
	12	13.2	0.00–0.29
	24	6.61	0.00–0.19

^aPrimary lesions in hepatocellular, gastric, lung carcinoma, other carcinoma and sarcoma, breast, prostate, thyroid carcinoma

^bmeasured with Mann-Whitney test

^cmeasured with Fisher's exact probability test. ECOG, Eastern Cooperative Oncology Group; CI, confidence interval.